Three U.S. Senators introduced new legislation last week in an effort to bolster treatment innovation by pharmaceutical companies for rare and neglected pediatric diseases. Sens. Sherrod Brown (D-OH), Sam Brownback (R-KS) and Al Franken (D-MN) proposed The Creating Hope Act of 2010 (S. 3697) in a bipartisan effort that builds on the FDA Amendments Act […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
When provinces in Canada lifted restrictions pegging eligibility for treatment for hepatitis C with direct-acting antivirals to the stage of the disease — or range of […]